Drugs (Prices Control) Order, 2013
Rules made under Essential Commodities Act, 1955
- Made under: Essential Commodities Act, 1955
Contents
- Rule 1 - Short title and commencement
- Rule 2 - Definitions
- Rule 3 - Directions to manufacturers of active pharmaceutical ingredients or bulk drugs or formulations
- Rule 4 - Calculation of ceiling price of a scheduled formulation
- Rule 5 - Calculation of retail price of a new drug for existing manufacturers of scheduled formulations
- Rule 6 - Ceiling price of a scheduled formulation in case of no reduction in price due to absence of competition
- Rule 7 - Margin to retailer
- Rule 8 - Maximum retail price
- Rule 9 - Reference data and source of market based data
- Rule 10 - Pricing of the formulations covered under Drugs (Prices Control) Order, 1995
- Rule 11 - Ceiling price or retail price of a pack
- Rule 12 - Price of formulations (branded or generic version) listed in the National List of Essential Medicines, launched by a manufacturer
- Rule 13 - Price of scheduled formulations for the existing manufacturers
- Rule 14 - Fixation of ceiling price of scheduled formulations
- Rule 15 - Fixation of retail price of a new drug for existing manufacturers of scheduled formulations
- Rule 16 - Revision of ceiling price of scheduled formulations
- Rule 17 - Amendment of the list of scheduled formulation
- Rule 18 - Revision of ceiling price on the basis of moving annual turnover (MAT)
- Rule 19 - Fixation of ceiling price of a drug under certain circumstances
- Rule 20 - Monitoring the prices of non-scheduled formulations
- Rule 21 - Monitoring the availability of scheduled formulations
- Rule 22 - Recovery of dues accrued under the Drugs (Prices Control) Order, 1979 and to deposit the same into the Drugs Prices Equalisation Account
- Rule 23 - Recovery of overcharged amount under Drugs Prices Control Orders 1987 and 1995
- Rule 24 - Carrying into effect the price fixed or revised by the Government, its display and proof thereof
- Rule 25 - Display of prices of non-scheduled formulations and price list thereof
- Rule 26 - Control of sale prices of formulations
- Rule 27 - Sale of split quantities of formulations
- Rule 28 - Manufacturer, distributor or dealer not to refuse sale of drug
- Rule 29 - Maintenance of records and production thereof for inspection
- Rule 30 - Power of entry, search and seizure
- Rule 31 - Power to review
- Rule 32 - Non–application of the provisions of this order in certain cases